<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://m2.mtmt.hu/xsl/gui3.xsl" ?>
<myciteResult>
  <serverUrl>https://m2.mtmt.hu/</serverUrl>
  <labelLang>hun</labelLang>
  <responseDate>2026-09-20 17:23</responseDate>
  <content>
    <publication>
      <otype>JournalArticle</otype>
      <mtid>34405975</mtid>
      <status>VALIDATED</status>
      <published>true</published>
      <unhandledTickets>0</unhandledTickets>
      <deleted>false</deleted>
      <lastRefresh>2026-09-18T10:22:22.500+0000</lastRefresh>
      <lastModified>2025-07-11T07:56:11.104+0000</lastModified>
      <created>2023-11-29T10:26:49.490+0000</created>
      <creator>
        <snippet>true</snippet>
        <mtid>10015206</mtid>
        <familyName>Áncsán</familyName>
        <givenName>Gizella</givenName>
        <link>/api/admin/10015206</link>
        <otype>Admin</otype>
        <label>Áncsán Gizella (SE admin)</label>
        <published>true</published>
        <oldId>10015206</oldId>
      </creator>
      <lastDuplumOK>2026-06-02T12:00:57.980+0000</lastDuplumOK>
      <lastDuplumSearch>2026-06-02T12:00:57.980+0000</lastDuplumSearch>
      <validated>2024-01-09T07:21:02.671+0000</validated>
      <validator>
        <snippet>true</snippet>
        <mtid>10080205</mtid>
        <familyName>Szalóky-Siki</familyName>
        <givenName>Ágnes</givenName>
        <link>/api/admin/10080205</link>
        <otype>Admin</otype>
        <label>Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin)</label>
        <published>true</published>
      </validator>
      <core>true</core>
      <publicationPending>false</publicationPending>
      <type>
        <snippet>true</snippet>
        <mtid>24</mtid>
        <code>24</code>
        <link>/api/publicationtype/24</link>
        <otype>PublicationType</otype>
        <label>Folyóiratcikk</label>
        <listPosition>1</listPosition>
        <published>true</published>
        <oldId>24</oldId>
        <otypeName>JournalArticle</otypeName>
      </type>
      <subType>
        <snippet>true</snippet>
        <mtid>1134514</mtid>
        <nameEng>Survey paper</nameEng>
        <docType>
          <snippet>true</snippet>
          <mtid>24</mtid>
          <code>24</code>
          <link>/api/publicationtype/24</link>
          <otype>PublicationType</otype>
          <label>Folyóiratcikk</label>
          <listPosition>1</listPosition>
          <published>true</published>
          <oldId>24</oldId>
          <otypeName>JournalArticle</otypeName>
        </docType>
        <link>/api/subtype/1134514</link>
        <name>Összefoglaló cikk</name>
        <otype>SubType</otype>
        <label>Összefoglaló cikk (Folyóiratcikk)</label>
        <listPosition>102</listPosition>
        <published>true</published>
        <oldId>1134514</oldId>
      </subType>
      <category>
        <snippet>true</snippet>
        <mtid>1</mtid>
        <link>/api/category/1</link>
        <otype>Category</otype>
        <label>Tudományos</label>
        <published>true</published>
        <oldId>1</oldId>
      </category>
      <firstAuthor>Magramane, Sabrina</firstAuthor>
      <title>Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements</title>
      <journal>
        <snippet>true</snippet>
        <sciIndexed>true</sciIndexed>
        <link>/api/journal/10024432</link>
        <reviewType>REVIEWED</reviewType>
        <label>PHARMACEUTICALS 1424-8247</label>
        <published>true</published>
        <hungarian>false</hungarian>
        <oldId>10024432</oldId>
        <noIF>false</noIF>
        <mtid>10024432</mtid>
        <scopusIndexed>true</scopusIndexed>
        <eIssn>1424-8247</eIssn>
        <otype>Journal</otype>
        <lang>FOREIGN</lang>
      </journal>
      <volume>16</volume>
      <issue>12</issue>
      <internalId>1658</internalId>
      <firstPageOrInternalIdForSort>1658</firstPageOrInternalIdForSort>
      <pageLength>48</pageLength>
      <publishedYear>2023</publishedYear>
      <abstractText>In this review, an extensive analysis of dry powder inhalers (DPIs) is offered, focusing on their characteristics, formulation, stability, and manufacturing. The advantages of pulmonary delivery were investigated, as well as the significance of the particle size in drug deposition. The preparation of DPI formulations was also comprehensively explored, including physico-chemical characterization of powders, powder processing techniques, and formulation considerations. In addition to manufacturing procedures, testing methods were also discussed, providing insights into the development and evaluation of DPI formulations. This review also explores the design basics and critical attributes specific to DPIs, highlighting the significance of their optimization to achieve an effective inhalation therapy. Additionally, the morphology and stability of 3 DPI capsules (Spiriva, Braltus, and Onbrez) were investigated, offering valuable insights into the properties of these formulations. Altogether, these findings contribute to a deeper understanding of DPIs and their development, performance, and optimization of inhalation dosage forms.</abstractText>
      <digital>true</digital>
      <printed/>
      <sourceYear>2023</sourceYear>
      <foreignEdition>true</foreignEdition>
      <foreignLanguage>true</foreignLanguage>
      <fullPublication>true</fullPublication>
      <conferencePublication>false</conferencePublication>
      <nationalOrigin>true</nationalOrigin>
      <missingAuthor>false</missingAuthor>
      <oaType>GOLD</oaType>
      <oaCheckDate>2026-09-18</oaCheckDate>
      <oaFree>true</oaFree>
      <oaLink>https://doi.org/10.3390/ph16121658</oaLink>
      <citationCount>53</citationCount>
      <citationCountUnpublished>0</citationCountUnpublished>
      <citationCountWoOther>53</citationCountWoOther>
      <independentCitCountWoOther>52</independentCitCountWoOther>
      <nationalOriginCitationCount>1</nationalOriginCitationCount>
      <foreignEditionCitationCount>52</foreignEditionCitationCount>
      <doiCitationCount>48</doiCitationCount>
      <wosCitationCount>37</wosCitationCount>
      <scopusCitationCount>43</scopusCitationCount>
      <wosScopusCitationCount>44</wosScopusCitationCount>
      <wosScopusCitationCountWoOther>44</wosScopusCitationCountWoOther>
      <wosScopusIndependentCitationCount>43</wosScopusIndependentCitationCount>
      <wosScopusIndependentCitationCountWoOther>43</wosScopusIndependentCitationCountWoOther>
      <independentCitationCount>52</independentCitationCount>
      <selfCitationCount>1</selfCitationCount>
      <unhandledCitationCount>0</unhandledCitationCount>
      <citingPubCount>53</citingPubCount>
      <independentCitingPubCount>52</independentCitingPubCount>
      <citingPubCountWoOther>53</citingPubCountWoOther>
      <independentCitingPubCountWoOther>52</independentCitingPubCountWoOther>
      <unhandledCitingPubCount>0</unhandledCitingPubCount>
      <citedPubCount>3</citedPubCount>
      <citedCount>3</citedCount>
      <pubStats>
        <types>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <count>47</count>
        </types>
        <types>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <count>4</count>
        </types>
        <types>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <count>1</count>
        </types>
        <types>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <count>1</count>
        </types>
        <types>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <count>0</count>
        </types>
        <types>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <count>0</count>
        </types>
        <types>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <count>0</count>
        </types>
        <types>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <count>0</count>
        </types>
        <types>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <count>0</count>
        </types>
        <citationTypes>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <years>
          <year>2024</year>
          <publicationCount>0</publicationCount>
          <citationCount>6</citationCount>
          <independentCitationCount>6</independentCitationCount>
          <citingPubCount>6</citingPubCount>
          <independentCitingPubCount>6</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2025</year>
          <publicationCount>0</publicationCount>
          <citationCount>28</citationCount>
          <independentCitationCount>27</independentCitationCount>
          <citingPubCount>28</citingPubCount>
          <independentCitingPubCount>27</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2026</year>
          <publicationCount>0</publicationCount>
          <citationCount>19</citationCount>
          <independentCitationCount>19</independentCitationCount>
          <citingPubCount>19</citingPubCount>
          <independentCitingPubCount>19</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
      </pubStats>
      <ratingsForSort>Q1</ratingsForSort>
      <hasCitationDuplums>false</hasCitationDuplums>
      <importDuplum>false</importDuplum>
      <importOverwritten>false</importOverwritten>
      <importSkipped>false</importSkipped>
      <userChangeableUntil>2024-01-08T07:21:02.377+0000</userChangeableUntil>
      <directInstitutesForSort>Egyetemi Gyógyszertár Gyógyszerügyi Szervezési ... (SE / GYTK); Elektronikai Technológia Tanszék (BME / VIK); Gyógyszerészeti Intézet (SE / GYTK)</directInstitutesForSort>
      <ownerAuthorCount>7</ownerAuthorCount>
      <ownerInstituteCount>11</ownerInstituteCount>
      <directInstituteCount>3</directInstituteCount>
      <authorCount>7</authorCount>
      <contributorCount>0</contributorCount>
      <hasQualityFactor>true</hasQualityFactor>
      <languages>
        <language>
          <otype>Language</otype>
          <mtid>10002</mtid>
          <link>/api/language/10002</link>
          <label>Angol</label>
          <name>Angol</name>
          <nameEng>English</nameEng>
          <published>true</published>
          <oldId>2</oldId>
          <snippet>true</snippet>
        </language>
      </languages>
      <authorships>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>112426640</mtid>
          <link>/api/authorship/112426640</link>
          <label>Magramane, Sabrina [MAGRAMANE, Sabrina (Pharmacy), szerző] Gyógyszerészeti Intézet (SE / GYTK)</label>
          <listPosition>1</listPosition>
          <share>0.143</share>
          <first>true</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10071684</mtid>
            <link>/api/author/10071684</link>
            <label>MAGRAMANE Sabrina (Pharmacy)</label>
            <familyName>MAGRAMANE</familyName>
            <givenName>Sabrina</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Magramane</familyName>
          <givenName>Sabrina</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>112426641</mtid>
          <link>/api/authorship/112426641</link>
          <label>Vlahović, Kristina [Vlahovic, Kristina (gyógyszertechnológia), szerző] Gyógyszerészeti Intézet (SE / GYTK)</label>
          <listPosition>2</listPosition>
          <share>0.143</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10087474</mtid>
            <link>/api/author/10087474</link>
            <label>Vlahovic Kristina (gyógyszertechnológia)</label>
            <familyName>Vlahovic</familyName>
            <givenName>Kristina</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Vlahović</familyName>
          <givenName>Kristina</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>112426642</mtid>
          <link>/api/authorship/112426642</link>
          <label>Gordon, Péter [Gordon, Péter (Hibaanalitika), szerző] Elektronikai Technológia Tanszék (BME / VIK)</label>
          <listPosition>3</listPosition>
          <share>0.14285715</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10013580</mtid>
            <link>/api/author/10013580</link>
            <label>Gordon Péter (Hibaanalitika)</label>
            <familyName>Gordon</familyName>
            <givenName>Péter</givenName>
            <published>true</published>
            <oldId>10013580</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Gordon</familyName>
          <givenName>Péter</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>112426643</mtid>
          <link>/api/authorship/112426643</link>
          <label>Kállai-Szabó, Nikolett ✉ [Kállai-Szabó, Nikolett (Gyógyszertechnológia), szerző] Gyógyszerészeti Intézet (SE / GYTK)</label>
          <listPosition>4</listPosition>
          <share>0.143</share>
          <first>false</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10020629</mtid>
            <link>/api/author/10020629</link>
            <label>Kállai-Szabó Nikolett (Gyógyszertechnológia)</label>
            <familyName>Kállai-Szabó</familyName>
            <givenName>Nikolett</givenName>
            <published>true</published>
            <oldId>10020629</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Kállai-Szabó</familyName>
          <givenName>Nikolett</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>112426644</mtid>
          <link>/api/authorship/112426644</link>
          <label>Zelkó, Romána [Zelkó, Romána (Gyógyszertechnológia), szerző] Egyetemi Gyógyszertár Gyógyszerügyi Szervezési ... (SE / GYTK)</label>
          <listPosition>5</listPosition>
          <share>0.143</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10002587</mtid>
            <link>/api/author/10002587</link>
            <label>Zelkó Romána (Gyógyszertechnológia)</label>
            <familyName>Zelkó</familyName>
            <givenName>Romána</givenName>
            <published>true</published>
            <oldId>10002587</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Zelkó</familyName>
          <givenName>Romána</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>112426645</mtid>
          <link>/api/authorship/112426645</link>
          <label>Antal, István [Antal, István (Gyógyszertechnológia), szerző] Gyógyszerészeti Intézet (SE / GYTK)</label>
          <listPosition>6</listPosition>
          <share>0.143</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10020626</mtid>
            <link>/api/author/10020626</link>
            <label>Antal István (Gyógyszertechnológia)</label>
            <familyName>Antal</familyName>
            <givenName>István</givenName>
            <published>true</published>
            <oldId>10020626</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Antal</familyName>
          <givenName>István</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>112426646</mtid>
          <link>/api/authorship/112426646</link>
          <label>Farkas, Dóra ✉ [Farkas, Dóra (gyógyszertechnológia), szerző] Gyógyszerészeti Intézet (SE / GYTK)</label>
          <listPosition>7</listPosition>
          <share>0.143</share>
          <first>false</first>
          <last>true</last>
          <corresponding>true</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10061229</mtid>
            <link>/api/author/10061229</link>
            <label>Farkas Dóra (gyógyszertechnológia)</label>
            <familyName>Farkas</familyName>
            <givenName>Dóra</givenName>
            <published>true</published>
            <oldId>10061229</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Farkas</familyName>
          <givenName>Dóra</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
      </authorships>
      <identifiers>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>25037979</mtid>
          <link>/api/publicationidentifier/25037979</link>
          <label>DOI: 10.3390/ph16121658</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>6</mtid>
            <link>/api/publicationsource/6</link>
            <label>DOI</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10001</mtid>
              <link>/api/publicationsourcetype/10001</link>
              <label>DOI</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>DOI</name>
            <nameEng>DOI</nameEng>
            <linkPattern>https://doi.org/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>6</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>GOLD</oaType>
          <oaFree>true</oaFree>
          <validState>IDENTICAL</validState>
          <idValue>10.3390/ph16121658</idValue>
          <realUrl>https://doi.org/10.3390/ph16121658</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>25324087</mtid>
          <link>/api/publicationidentifier/25324087</link>
          <label>WoS: 001131093800001</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>1</mtid>
            <link>/api/publicationsource/1</link>
            <label>WoS</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>WoS</name>
            <nameEng>WoS</nameEng>
            <linkPattern>https://www.webofscience.com/wos/woscc/full-record/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>1</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>001131093800001</idValue>
          <realUrl>https://www.webofscience.com/wos/woscc/full-record/001131093800001</realUrl>
          <published>true</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>25250931</mtid>
          <link>/api/publicationidentifier/25250931</link>
          <label>Scopus: 85180680047</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>3</mtid>
            <link>/api/publicationsource/3</link>
            <label>Scopus</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Scopus</name>
            <nameEng>Scopus</nameEng>
            <linkPattern>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>3</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>85180680047</idValue>
          <realUrl>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85180680047</realUrl>
          <published>true</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>25250951</mtid>
          <link>/api/publicationidentifier/25250951</link>
          <label>PubMed: 38139785</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>17</mtid>
            <link>/api/publicationsource/17</link>
            <label>PubMed</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>PubMed</name>
            <nameEng>PubMed</nameEng>
            <linkPattern>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=@@@&amp;dopt=Abstract</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>17</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>38139785</idValue>
          <realUrl>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=38139785&amp;dopt=Abstract</realUrl>
          <published>true</published>
          <snippet>true</snippet>
        </identifier>
      </identifiers>
      <ratings>
        <rating>
          <otype>SjrRating</otype>
          <mtid>11405946</mtid>
          <link>/api/sjrrating/11405946</link>
          <label>sjr:Q1 (2023) Scopus - Pharmaceutical Science PHARMACEUTICALS 1424-8247</label>
          <listPos>32</listPos>
          <rankValue>0.24</rankValue>
          <type>journal</type>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10002</mtid>
            <link>/api/ratingtype/10002</link>
            <label>sjr</label>
            <code>sjr</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <subject>
            <otype>ClassificationExternal</otype>
            <mtid>3003</mtid>
            <link>/api/classificationexternal/3003</link>
            <label>Scopus - Pharmaceutical Science</label>
            <published>true</published>
            <oldId>3003</oldId>
            <snippet>true</snippet>
          </subject>
          <ranking>Q1</ranking>
          <calculation>DIRECT</calculation>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
      </ratings>
      <references>
        <reference>
          <otype>Reference</otype>
          <mtid>47478504</mtid>
          <link>/api/reference/47478504</link>
          <label>1. Anderson 2005: History of Aerosol Therapy: Liquid Nebulization to MDIs to DPIs., Respir. Care, 50, p. 1139</label>
          <listPosition>1</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478505</mtid>
          <link>/api/reference/47478505</link>
          <label>2. Stein 2017: The History of Therapeutic Aerosols: A Chronological Review., J. Aerosol Med. Pulm. Drug Deliv., 30, p. 20, DOI: 10.1089/jamp.2016.1297</label>
          <listPosition>2</listPosition>
          <doi>10.1089/jamp.2016.1297</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478506</mtid>
          <link>/api/reference/47478506</link>
          <label>3. Lee 2015: Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges., Asian J. Pharm. Sci., 10, p. 481, DOI: 10.1016/j.ajps.2015.08.009</label>
          <listPosition>3</listPosition>
          <doi>10.1016/j.ajps.2015.08.009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478507</mtid>
          <link>/api/reference/47478507</link>
          <label>4. Ambrus 2018: Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties., Eur. J. Pharm. Sci., 123, p. 20, DOI: 10.1016/j.ejps.2018.07.030</label>
          <listPosition>4</listPosition>
          <doi>10.1016/j.ejps.2018.07.030</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478508</mtid>
          <link>/api/reference/47478508</link>
          <label>5. Yacoub 2015: Inhaled nano- and microparticles for drug delivery., Glob. Cardiol. Sci. Pract., 2015, p. 2, DOI: 10.5339/gcsp.2015.2</label>
          <listPosition>5</listPosition>
          <doi>10.5339/gcsp.2015.2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478509</mtid>
          <link>/api/reference/47478509</link>
          <label>6. Ashley 2022: The environmental impact of inhaled therapy: Making informed treatment choices., Eur. Respir. J., 60, p. 2102106, DOI: 10.1183/13993003.02106-2021</label>
          <listPosition>6</listPosition>
          <doi>10.1183/13993003.02106-2021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478510</mtid>
          <link>/api/reference/47478510</link>
          <label>7. Buttini, F., Quarta, E., Allegrini, C., and Lavorini, F. (2021). Understanding the Importance of Capsules in Dry Powder Inhalers. Pharmaceutics, 13., DOI: 10.3390/pharmaceutics13111936</label>
          <listPosition>7</listPosition>
          <doi>10.3390/pharmaceutics13111936</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478511</mtid>
          <link>/api/reference/47478511</link>
          <label>8. Hagedoorn 2017: Dry powder inhalation: Past, present and future., Expert Opin. Drug Deliv., 14, p. 499, DOI: 10.1080/17425247.2016.1224846</label>
          <listPosition>8</listPosition>
          <doi>10.1080/17425247.2016.1224846</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478512</mtid>
          <link>/api/reference/47478512</link>
          <label>9. Bhuiyan 2018: Metered dose inhaler (MDI) versus dry powder inhaler (DPI): Patient’s compliance variation in asthma medication at rural Bangladesh perspective., J. Dent. Med. Sci., 17, p. 66</label>
          <listPosition>9</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478513</mtid>
          <link>/api/reference/47478513</link>
          <label>10. (2023, July 31). Clinical Trials, Available online: https://www.clinicaltrials.gov/ct2/home.</label>
          <listPosition>10</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478514</mtid>
          <link>/api/reference/47478514</link>
          <label>11. Nelson 2016: Inhalation devices, delivery systems, and patient technique., Ann. Allergy Asthma Immunol., 117, p. 606, DOI: 10.1016/j.anai.2016.05.006</label>
          <listPosition>11</listPosition>
          <doi>10.1016/j.anai.2016.05.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478515</mtid>
          <link>/api/reference/47478515</link>
          <label>12. Rajendran 2015: Recent modalities in drug delivery via inhalation therapy–An advanced treatment strategy for pulmonary Carcinoma., Int. J. Pharm. Pharm. Sci., 7, p. 8</label>
          <listPosition>12</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478516</mtid>
          <link>/api/reference/47478516</link>
          <label>13. Hickey 2013: Back to the future: Inhaled drug products., J. Pharm. Sci., 102, p. 1165, DOI: 10.1002/jps.23465</label>
          <listPosition>13</listPosition>
          <doi>10.1002/jps.23465</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478517</mtid>
          <link>/api/reference/47478517</link>
          <label>14. Weber 2014: Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art., Eur. J. Pharm. Biopharm., 86, p. 7, DOI: 10.1016/j.ejpb.2013.08.013</label>
          <listPosition>14</listPosition>
          <doi>10.1016/j.ejpb.2013.08.013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478518</mtid>
          <link>/api/reference/47478518</link>
          <label>15. Lexmond 2017: Drug Delivery Devices for Inhaled Medicines., Handb. Exp. Pharmacol., 237, p. 265, DOI: 10.1007/164_2016_67</label>
          <listPosition>15</listPosition>
          <doi>10.1007/164_2016_67</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478519</mtid>
          <link>/api/reference/47478519</link>
          <label>16. Rangaraj 2019: Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements., Pulm. Pharmacol. Ther., 54, p. 1, DOI: 10.1016/j.pupt.2018.11.004</label>
          <listPosition>16</listPosition>
          <doi>10.1016/j.pupt.2018.11.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478520</mtid>
          <link>/api/reference/47478520</link>
          <label>17. Darquenne 2020: Deposition Mechanisms., J. Aerosol Med. Pulm. Drug Deliv., 33, p. 181, DOI: 10.1089/jamp.2020.29029.cd</label>
          <listPosition>17</listPosition>
          <doi>10.1089/jamp.2020.29029.cd</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478521</mtid>
          <link>/api/reference/47478521</link>
          <label>18. Darquenne 2012: Aerosol deposition in health and disease., J. Aerosol Med. Pulm. Drug Deliv., 25, p. 140, DOI: 10.1089/jamp.2011.0916</label>
          <listPosition>18</listPosition>
          <doi>10.1089/jamp.2011.0916</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478522</mtid>
          <link>/api/reference/47478522</link>
          <label>19. James 1994: deposition of inhaled particles., Ann. ICRP, 24, p. 231, DOI: 10.1016/0146-6453(94)90042-6</label>
          <listPosition>19</listPosition>
          <doi>10.1016/0146-6453(94)90042-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478523</mtid>
          <link>/api/reference/47478523</link>
          <label>20. Peng 2016: Influence of physical properties of carrier on the performance of dry powder inhalers., Acta Pharm. Sin. B, 6, p. 308, DOI: 10.1016/j.apsb.2016.03.011</label>
          <listPosition>20</listPosition>
          <doi>10.1016/j.apsb.2016.03.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478524</mtid>
          <link>/api/reference/47478524</link>
          <label>21. Yang 2014: Pulmonary drug delivery by powder aerosols., J. Control. Release, 193, p. 228, DOI: 10.1016/j.jconrel.2014.04.055</label>
          <listPosition>21</listPosition>
          <doi>10.1016/j.jconrel.2014.04.055</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478525</mtid>
          <link>/api/reference/47478525</link>
          <label>22. Kleinstreuer 2007: Combined inertial and gravitational deposition of microparticles in small model airways of a human respiratory system., J. Aerosol Sci., 38, p. 1047, DOI: 10.1016/j.jaerosci.2007.08.010</label>
          <listPosition>22</listPosition>
          <doi>10.1016/j.jaerosci.2007.08.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478526</mtid>
          <link>/api/reference/47478526</link>
          <label>23. Labiris 2003: Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications., Br. J. Clin. Pharmacol., 56, p. 588, DOI: 10.1046/j.1365-2125.2003.01892.x</label>
          <listPosition>23</listPosition>
          <doi>10.1046/j.1365-2125.2003.01892.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478527</mtid>
          <link>/api/reference/47478527</link>
          <label>24. Patton 1996: Mechanisms of macromolecule absorption by the lungs., Adv. Drug Deliv. Rev., 19, p. 3, DOI: 10.1016/0169-409X(95)00113-L</label>
          <listPosition>24</listPosition>
          <doi>10.1016/0169-409X(95)00113-L</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478528</mtid>
          <link>/api/reference/47478528</link>
          <label>25. Zanen 1996: Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction., Thorax, 51, p. 977, DOI: 10.1136/thx.51.10.977</label>
          <listPosition>25</listPosition>
          <doi>10.1136/thx.51.10.977</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478529</mtid>
          <link>/api/reference/47478529</link>
          <label>26. Cha 2017: Inhalation Therapy in Horses., Vet. Clin. N. Am. Equine Pract., 33, p. 29, DOI: 10.1016/j.cveq.2016.11.007</label>
          <listPosition>26</listPosition>
          <doi>10.1016/j.cveq.2016.11.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478530</mtid>
          <link>/api/reference/47478530</link>
          <label>27. Anselmo 2019: Non-invasive delivery strategies for biologics., Nat. Rev. Drug Discov., 18, p. 19, DOI: 10.1038/nrd.2018.183</label>
          <listPosition>27</listPosition>
          <doi>10.1038/nrd.2018.183</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478531</mtid>
          <link>/api/reference/47478531</link>
          <label>28. Hoppentocht 2014: Technological and practical challenges of dry powder inhalers and formulations., Adv. Drug Deliv. Rev., 75, p. 18, DOI: 10.1016/j.addr.2014.04.004</label>
          <listPosition>28</listPosition>
          <doi>10.1016/j.addr.2014.04.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478532</mtid>
          <link>/api/reference/47478532</link>
          <label>29. Shetty 2020: Physical stability of dry powder inhaler formulations., Expert Opin. Drug Deliv., 17, p. 77, DOI: 10.1080/17425247.2020.1702643</label>
          <listPosition>29</listPosition>
          <doi>10.1080/17425247.2020.1702643</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478533</mtid>
          <link>/api/reference/47478533</link>
          <label>30. Lau 2017: Co-milled API-lactose systems for inhalation therapy: Impact of magnesium stearate on physico-chemical stability and aerosolization performance., Drug Dev. Ind. Pharm., 43, p. 980, DOI: 10.1080/03639045.2017.1287719</label>
          <listPosition>30</listPosition>
          <doi>10.1080/03639045.2017.1287719</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478534</mtid>
          <link>/api/reference/47478534</link>
          <label>31. Chougule 2007: Development of dry powder inhalers., Recent Pat. Drug Deliv. Formul., 1, p. 11, DOI: 10.2174/187221107779814159</label>
          <listPosition>31</listPosition>
          <doi>10.2174/187221107779814159</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478535</mtid>
          <link>/api/reference/47478535</link>
          <label>32. Gradon 2014: Formation of particles for dry powder inhalers., Adv. Powder Technol., 25, p. 43, DOI: 10.1016/j.apt.2013.09.012</label>
          <listPosition>32</listPosition>
          <doi>10.1016/j.apt.2013.09.012</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478536</mtid>
          <link>/api/reference/47478536</link>
          <label>33. Chang 2022: Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics., Pharm. Res., 39, p. 3047, DOI: 10.1007/s11095-022-03363-2</label>
          <listPosition>33</listPosition>
          <doi>10.1007/s11095-022-03363-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478537</mtid>
          <link>/api/reference/47478537</link>
          <label>34. Ruangchayajatuporn 2011: Compaction behavior and optimization of spray-dried lactose with various amorphous content., J. Drug Deliv. Sci. Technol., 21, p. 175, DOI: 10.1016/S1773-2247(11)50019-X</label>
          <listPosition>34</listPosition>
          <doi>10.1016/S1773-2247(11)50019-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478538</mtid>
          <link>/api/reference/47478538</link>
          <label>35. Vromans 1987: Studies on tableting properties of lactose. VII. The effect of variations in primary particle size and percentage of amorphous lactose in spray dried lactose products., Int. J. Pharm., 35, p. 29, DOI: 10.1016/0378-5173(87)90071-8</label>
          <listPosition>35</listPosition>
          <doi>10.1016/0378-5173(87)90071-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478539</mtid>
          <link>/api/reference/47478539</link>
          <label>36. Haferkamp, L., Haudenschild, L., Spierings, A., Wegener, K., Riener, K., Ziegelmeier, S., and Leichtfried, G.J. (2021). The Influence of Particle Shape, Powder Flowability, and Powder Layer Density on Part Density in Laser Powder Bed Fusion. Metals, 11., DOI: 10.3390/met11030418</label>
          <listPosition>36</listPosition>
          <doi>10.3390/met11030418</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478540</mtid>
          <link>/api/reference/47478540</link>
          <label>37. Rassu 2006: Tableting properties of an improved spray-dried lactose., J. Drug Deliv. Sci. Technol., 16, p. 455, DOI: 10.1016/S1773-2247(06)50087-5</label>
          <listPosition>37</listPosition>
          <doi>10.1016/S1773-2247(06)50087-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478541</mtid>
          <link>/api/reference/47478541</link>
          <label>38. (2023, November 10). Available online: https://www.vectura.com/services/formulation/dry-powder-formulation-development/.</label>
          <listPosition>38</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478542</mtid>
          <link>/api/reference/47478542</link>
          <label>39. Chan 2013: Aerosol Delivery of Nanoparticles in Uniform Mannitol Carriers Formulated by Ultrasonic Spray Freeze Drying., Pharm. Res., 30, p. 2891, DOI: 10.1007/s11095-013-1120-6</label>
          <listPosition>39</listPosition>
          <doi>10.1007/s11095-013-1120-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478543</mtid>
          <link>/api/reference/47478543</link>
          <label>40. Liu, G., Li, J., and Deng, S. (2021). Applications of Supercritical Anti-Solvent Process in Preparation of Solid Multicomponent Systems. Pharmaceutics, 13., DOI: 10.3390/pharmaceutics13040475</label>
          <listPosition>40</listPosition>
          <doi>10.3390/pharmaceutics13040475</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478544</mtid>
          <link>/api/reference/47478544</link>
          <label>41. Nikolaou 2018: Electrohydrodynamic methods for the development of pulmonary drug delivery systems., Eur. J. Pharm. Sci., 113, p. 29, DOI: 10.1016/j.ejps.2017.08.032</label>
          <listPosition>41</listPosition>
          <doi>10.1016/j.ejps.2017.08.032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478545</mtid>
          <link>/api/reference/47478545</link>
          <label>42. Asiri, A.M., and Mohammad, A. (2018). Applications of Nanocomposite Materials in Drug Delivery, Woodhead Publishing.</label>
          <listPosition>42</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478546</mtid>
          <link>/api/reference/47478546</link>
          <label>43. Hiwrale 2023: Nanofibers: A current era in drug delivery system., Heliyon, 9, p. e18917, DOI: 10.1016/j.heliyon.2023.e18917</label>
          <listPosition>43</listPosition>
          <doi>10.1016/j.heliyon.2023.e18917</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478547</mtid>
          <link>/api/reference/47478547</link>
          <label>44. Li 2015: A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution., J. Control. Release, 204, p. 38, DOI: 10.1016/j.jconrel.2015.02.035</label>
          <listPosition>44</listPosition>
          <doi>10.1016/j.jconrel.2015.02.035</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478548</mtid>
          <link>/api/reference/47478548</link>
          <label>45. Wang 2014: In Vitro and In Vivo Performance of Dry Powder Inhalation Formulations: Comparison of Particles Prepared by Thin Film Freezing and Micronization., AAPS PharmSciTech, 15, p. 981, DOI: 10.1208/s12249-014-0126-7</label>
          <listPosition>45</listPosition>
          <doi>10.1208/s12249-014-0126-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478549</mtid>
          <link>/api/reference/47478549</link>
          <label>46. Pardeshi, S.R., Kole, E.B., Kapare, H.S., Chandankar, S.M., Shinde, P.J., Boisa, G.S., Salgaonkar, S.S., Giram, P.S., More, M.P., and Kolimi, P. (2022). Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations. Pharmaceutics, 14., DOI: 10.3390/pharmaceutics14122632</label>
          <listPosition>46</listPosition>
          <doi>10.3390/pharmaceutics14122632</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478550</mtid>
          <link>/api/reference/47478550</link>
          <label>47. Hufnagel 2022: The Development of Thin-Film Freezing and Its Application to Improve Delivery of Biologics as Dry Powder Aerosols., KONA Powder Part. J., 39, p. 176, DOI: 10.14356/kona.2022010</label>
          <listPosition>47</listPosition>
          <doi>10.14356/kona.2022010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478551</mtid>
          <link>/api/reference/47478551</link>
          <label>48. Praphawatvet 2022: Pharmaceutical dry powders of small molecules prepared by thin-film freezing and their applications–A focus on the physical and aerosol properties of the powders., Int. J. Pharm., 629, p. 122357, DOI: 10.1016/j.ijpharm.2022.122357</label>
          <listPosition>48</listPosition>
          <doi>10.1016/j.ijpharm.2022.122357</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478552</mtid>
          <link>/api/reference/47478552</link>
          <label>49. (2023, November 10). Available online: https://tffpharma.com/.</label>
          <listPosition>49</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478553</mtid>
          <link>/api/reference/47478553</link>
          <label>50. Abdellah 2015: Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients., Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc., 23, p. 9</label>
          <listPosition>50</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478554</mtid>
          <link>/api/reference/47478554</link>
          <label>51. Prime 1997: Review of dry powder inhalers., Adv. Drug Deliv. Rev., 26, p. 51, DOI: 10.1016/S0169-409X(97)00510-3</label>
          <listPosition>51</listPosition>
          <doi>10.1016/S0169-409X(97)00510-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478555</mtid>
          <link>/api/reference/47478555</link>
          <label>52. Pilcer 2012: Lactose characteristics and the generation of the aerosol., Adv. Drug Deliv. Rev., 64, p. 233, DOI: 10.1016/j.addr.2011.05.003</label>
          <listPosition>52</listPosition>
          <doi>10.1016/j.addr.2011.05.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478556</mtid>
          <link>/api/reference/47478556</link>
          <label>53. Islam 2012: Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers., Med. Eng. Phys., 34, p. 409, DOI: 10.1016/j.medengphy.2011.12.025</label>
          <listPosition>53</listPosition>
          <doi>10.1016/j.medengphy.2011.12.025</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478557</mtid>
          <link>/api/reference/47478557</link>
          <label>54. Salomi 2018: The role of the solid state and physical properties of the carrier in adhesive mixtures for lung delivery., Expert Opin. Drug Deliv., 15, p. 665, DOI: 10.1080/17425247.2017.1371132</label>
          <listPosition>54</listPosition>
          <doi>10.1080/17425247.2017.1371132</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478558</mtid>
          <link>/api/reference/47478558</link>
          <label>55. Telko 2005: Dry Powder Inhaler Formulation., Respir. Care, 50, p. 1209</label>
          <listPosition>55</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478559</mtid>
          <link>/api/reference/47478559</link>
          <label>56. Larramendi 2013: Allergenicity of casein containing chalk in milk allergic schoolchildren., Ann. Allergy Asthma Immunol., 110, p. 335, DOI: 10.1016/j.anai.2013.02.006</label>
          <listPosition>56</listPosition>
          <doi>10.1016/j.anai.2013.02.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478560</mtid>
          <link>/api/reference/47478560</link>
          <label>57. Barbi 2004: Fatal allergy as a possible consequence of long-term elimination diet., Allergy, 59, p. 668, DOI: 10.1111/j.1398-9995.2004.00398.x</label>
          <listPosition>57</listPosition>
          <doi>10.1111/j.1398-9995.2004.00398.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478561</mtid>
          <link>/api/reference/47478561</link>
          <label>58. Morikawa 2016: A Case of Anaphylaxis in the Pediatric Patient with Milk Allergy Due to Traces of Milk Protein in the Lactose Used as an Excipient of Inavir Inhalation., Arerugi, 65, p. 200</label>
          <listPosition>58</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478562</mtid>
          <link>/api/reference/47478562</link>
          <label>59. Shapiro 2004: Contamination of dry powder inhalers for asthma with milk proteins containing lactose., J. Allergy Clin. Immunol., 113, p. 558, DOI: 10.1016/j.jaci.2003.11.015</label>
          <listPosition>59</listPosition>
          <doi>10.1016/j.jaci.2003.11.015</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478563</mtid>
          <link>/api/reference/47478563</link>
          <label>60. Robles 2014: Hypersensitivity reaction after inhalation of a lactose-containing dry powder inhaler., J. Pediatr. Pharmacol. Ther., 19, p. 206</label>
          <listPosition>60</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478564</mtid>
          <link>/api/reference/47478564</link>
          <label>61. Sa 2011: Reaction due to milk proteins contaminating lactose added to inhaled corticosteroid., J. Allergy Clin. Immunol., 127, p. AB241, DOI: 10.1016/j.jaci.2010.12.961</label>
          <listPosition>61</listPosition>
          <doi>10.1016/j.jaci.2010.12.961</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478565</mtid>
          <link>/api/reference/47478565</link>
          <label>62. Morisset 2006: Allergy to cow milk proteins contaminating lactose, common excipient of dry powder inhalers for asthma., J. Allergy Clin. Immunol., 117, p. S95, DOI: 10.1016/j.jaci.2005.12.379</label>
          <listPosition>62</listPosition>
          <doi>10.1016/j.jaci.2005.12.379</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478566</mtid>
          <link>/api/reference/47478566</link>
          <label>63. Bar-On, O., Levine, H., Stafler, P., Shmueli, E., Jacobi, E., Goldberg, O., Steuer, G., Prais, D., and Mei-Zahav, M. (2022). Lactose-Containing Dry-Powder Inhalers for Patients with Cow’s Milk Protein Allergy-The Conundrum; A National Survey of Pediatric Pulmonologists and Allergologists. J. Clin. Med., 11., DOI: 10.3390/jcm11247346</label>
          <listPosition>63</listPosition>
          <doi>10.3390/jcm11247346</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478567</mtid>
          <link>/api/reference/47478567</link>
          <label>64. Hagedoorn 2022: Dry powder inhalation, part 2: The present and future., Expert Opin. Drug Deliv., 19, p. 1045, DOI: 10.1080/17425247.2022.2112570</label>
          <listPosition>64</listPosition>
          <doi>10.1080/17425247.2022.2112570</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478568</mtid>
          <link>/api/reference/47478568</link>
          <label>65. Kaialy 2015: Dry powder inhalers: Physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol., Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci., 68, p. 56</label>
          <listPosition>65</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478569</mtid>
          <link>/api/reference/47478569</link>
          <label>66. Zhang 2009: A Perspective on the Maillard Reaction and the Analysis of Protein Glycation by Mass Spectrometry: Probing the Pathogenesis of Chronic Disease., J. Proteome Res., 8, p. 754, DOI: 10.1021/pr800858h</label>
          <listPosition>66</listPosition>
          <doi>10.1021/pr800858h</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478570</mtid>
          <link>/api/reference/47478570</link>
          <label>67. Zeng 1998: The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro., Int. J. Pharm., 176, p. 99, DOI: 10.1016/S0378-5173(98)00300-7</label>
          <listPosition>67</listPosition>
          <doi>10.1016/S0378-5173(98)00300-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478571</mtid>
          <link>/api/reference/47478571</link>
          <label>68. Jones 2006: The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations., Pharm. Res., 23, p. 1665, DOI: 10.1007/s11095-006-9012-7</label>
          <listPosition>68</listPosition>
          <doi>10.1007/s11095-006-9012-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478572</mtid>
          <link>/api/reference/47478572</link>
          <label>69. Young 2005: The influence of dose on the performance of dry powder inhalation systems., Int. J. Pharm., 296, p. 26, DOI: 10.1016/j.ijpharm.2005.02.004</label>
          <listPosition>69</listPosition>
          <doi>10.1016/j.ijpharm.2005.02.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478573</mtid>
          <link>/api/reference/47478573</link>
          <label>70. Pai 2016: Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin., J. Aerosol Med. Pulm. Drug Deliv., 29, p. 179, DOI: 10.1089/jamp.2014.1187</label>
          <listPosition>70</listPosition>
          <doi>10.1089/jamp.2014.1187</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478574</mtid>
          <link>/api/reference/47478574</link>
          <label>71. Alves, A.D., Cavaco, J.S., Guerreiro, F., Lourenço, J.P., Rosa da Costa, A.M., and Grenha, A. (2016). Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles. Molecules, 21., DOI: 10.3390/molecules21060702</label>
          <listPosition>71</listPosition>
          <doi>10.3390/molecules21060702</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478575</mtid>
          <link>/api/reference/47478575</link>
          <label>72. Devrim 2011: Preparation and evaluation of PLGA microparticles as carrier for the pulmonary delivery of rhIL-2 : I. Effects of some formulation parameters on microparticle characteristics., J. Microencapsul., 28, p. 582, DOI: 10.3109/02652048.2011.599438</label>
          <listPosition>72</listPosition>
          <doi>10.3109/02652048.2011.599438</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478576</mtid>
          <link>/api/reference/47478576</link>
          <label>73. Yildiz 2012: Inhaled extended-release microparticles of heparin elicit improved pulmonary pharmacodynamics against antigen-mediated airway hyper-reactivity and inflammation., J. Control. Release, 162, p. 456, DOI: 10.1016/j.jconrel.2012.07.008</label>
          <listPosition>73</listPosition>
          <doi>10.1016/j.jconrel.2012.07.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478577</mtid>
          <link>/api/reference/47478577</link>
          <label>74. Parumasivam 2016: Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization., Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci., 88, p. 1</label>
          <listPosition>74</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478578</mtid>
          <link>/api/reference/47478578</link>
          <label>75. Tavares 2017: Development of PLGA dry powder microparticles by supercritical CO2-assisted spray-drying for potential vaccine delivery to the lungs., J. Supercrit. Fluids, 128, p. 235, DOI: 10.1016/j.supflu.2017.06.004</label>
          <listPosition>75</listPosition>
          <doi>10.1016/j.supflu.2017.06.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478579</mtid>
          <link>/api/reference/47478579</link>
          <label>76. Doan 2011: Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery., Int. J. Pharm., 414, p. 112, DOI: 10.1016/j.ijpharm.2011.05.007</label>
          <listPosition>76</listPosition>
          <doi>10.1016/j.ijpharm.2011.05.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478580</mtid>
          <link>/api/reference/47478580</link>
          <label>77. Jensen 2012: Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA., J. Control. Release, 157, p. 141, DOI: 10.1016/j.jconrel.2011.08.011</label>
          <listPosition>77</listPosition>
          <doi>10.1016/j.jconrel.2011.08.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478581</mtid>
          <link>/api/reference/47478581</link>
          <label>78. Dimer 2015: Inhalable resveratrol microparticles produced by vibrational atomization spray drying for treating pulmonary arterial hypertension., J. Drug Deliv. Sci. Technol., 29, p. 152, DOI: 10.1016/j.jddst.2015.07.008</label>
          <listPosition>78</listPosition>
          <doi>10.1016/j.jddst.2015.07.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478582</mtid>
          <link>/api/reference/47478582</link>
          <label>79. Hariyadi 2022: Characterization of Dry Powder Inhaler Quercetin Solid Lipid Microparticle (SLM) as Lung Delivery System: Effect of Polymer Concentration., Egypt. J. Chem., 65, p. 281</label>
          <listPosition>79</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478583</mtid>
          <link>/api/reference/47478583</link>
          <label>80. Scalia 2013: Quercetin solid lipid microparticles: A flavonoid for inhalation lung delivery., Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci., 49, p. 278</label>
          <listPosition>80</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478584</mtid>
          <link>/api/reference/47478584</link>
          <label>81. Sansone 2009: Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying., Eur. J. Pharm. Biopharm., 72, p. 206, DOI: 10.1016/j.ejpb.2008.10.007</label>
          <listPosition>81</listPosition>
          <doi>10.1016/j.ejpb.2008.10.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478585</mtid>
          <link>/api/reference/47478585</link>
          <label>82. Prota 2011: Leucine enhances aerosol performance of naringin dry powder and its activity on cystic fibrosis airway epithelial cells., Int. J. Pharm., 412, p. 8, DOI: 10.1016/j.ijpharm.2011.03.055</label>
          <listPosition>82</listPosition>
          <doi>10.1016/j.ijpharm.2011.03.055</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478586</mtid>
          <link>/api/reference/47478586</link>
          <label>83. Corcoran 2013: Systemic delivery of atropine sulfate by the microdose dry-powder inhaler., J. Aerosol Med. Pulm. Drug Deliv., 26, p. 46, DOI: 10.1089/jamp.2011.0948</label>
          <listPosition>83</listPosition>
          <doi>10.1089/jamp.2011.0948</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478587</mtid>
          <link>/api/reference/47478587</link>
          <label>84. Kim 2012: Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer., Biomaterials, 33, p. 5574, DOI: 10.1016/j.biomaterials.2012.04.018</label>
          <listPosition>84</listPosition>
          <doi>10.1016/j.biomaterials.2012.04.018</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478588</mtid>
          <link>/api/reference/47478588</link>
          <label>85. Dhanda 2013: Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose., J. Control. Release, 168, p. 239, DOI: 10.1016/j.jconrel.2013.03.027</label>
          <listPosition>85</listPosition>
          <doi>10.1016/j.jconrel.2013.03.027</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478589</mtid>
          <link>/api/reference/47478589</link>
          <label>86. Ungaro 2010: Engineering gas-foamed large porous particles for efficient local delivery of macromolecules to the lung., Eur. J. Pharm. Sci., 41, p. 60, DOI: 10.1016/j.ejps.2010.05.011</label>
          <listPosition>86</listPosition>
          <doi>10.1016/j.ejps.2010.05.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478590</mtid>
          <link>/api/reference/47478590</link>
          <label>87. Zhang 2023: Spray freeze dried niclosamide nanocrystals embedded dry powder for high dose pulmonary delivery., Powder Technol., 415, p. 118168, DOI: 10.1016/j.powtec.2022.118168</label>
          <listPosition>87</listPosition>
          <doi>10.1016/j.powtec.2022.118168</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478591</mtid>
          <link>/api/reference/47478591</link>
          <label>88. Alipour 2010: Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery., Colloids Surf. B Biointerfaces, 81, p. 521, DOI: 10.1016/j.colsurfb.2010.07.050</label>
          <listPosition>88</listPosition>
          <doi>10.1016/j.colsurfb.2010.07.050</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478592</mtid>
          <link>/api/reference/47478592</link>
          <label>89. Siepmann 2012: Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying., Eur. J. Pharm. Biopharm., 81, p. 121, DOI: 10.1016/j.ejpb.2012.01.018</label>
          <listPosition>89</listPosition>
          <doi>10.1016/j.ejpb.2012.01.018</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478593</mtid>
          <link>/api/reference/47478593</link>
          <label>90. Adi 2010: Controlled release antibiotics for dry powder lung delivery., Drug Dev. Ind. Pharm., 36, p. 119, DOI: 10.3109/03639040903099769</label>
          <listPosition>90</listPosition>
          <doi>10.3109/03639040903099769</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478594</mtid>
          <link>/api/reference/47478594</link>
          <label>91. Abbas 2016: Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue., Colloids Surf. B Biointerfaces, 146, p. 19, DOI: 10.1016/j.colsurfb.2016.05.031</label>
          <listPosition>91</listPosition>
          <doi>10.1016/j.colsurfb.2016.05.031</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478595</mtid>
          <link>/api/reference/47478595</link>
          <label>92. Secret 2014: Enzyme-responsive hydrogel microparticles for pulmonary drug delivery., ACS Appl. Mater. Interfaces, 6, p. 10313, DOI: 10.1021/am501754s</label>
          <listPosition>92</listPosition>
          <doi>10.1021/am501754s</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478596</mtid>
          <link>/api/reference/47478596</link>
          <label>93. Pokharkar 2014: Single step spray drying method to develop proliposomes for inhalation: A systematic study based on quality by design approach., Pulm. Pharmacol. Ther., 27, p. 197, DOI: 10.1016/j.pupt.2013.07.006</label>
          <listPosition>93</listPosition>
          <doi>10.1016/j.pupt.2013.07.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478597</mtid>
          <link>/api/reference/47478597</link>
          <label>94. Yu 2020: Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells., Int. J. Pharm., 586, p. 119570, DOI: 10.1016/j.ijpharm.2020.119570</label>
          <listPosition>94</listPosition>
          <doi>10.1016/j.ijpharm.2020.119570</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478598</mtid>
          <link>/api/reference/47478598</link>
          <label>95. Cipolla, D., Blanchard, J., and Gonda, I. (2016). Development of Liposomal Ciprofloxacin to Treat Lung Infections. Pharmaceutics, 8., DOI: 10.3390/pharmaceutics8010006</label>
          <listPosition>95</listPosition>
          <doi>10.3390/pharmaceutics8010006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478599</mtid>
          <link>/api/reference/47478599</link>
          <label>96. Chimote 2010: In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis., J. Biomed Mater. Res. B Appl. Biomater., 94, p. 1, DOI: 10.1002/jbm.b.31608</label>
          <listPosition>96</listPosition>
          <doi>10.1002/jbm.b.31608</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478600</mtid>
          <link>/api/reference/47478600</link>
          <label>97. Chono 2017: Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary absorption of encapsulated insulin compared with co-administered insulin., Drug Dev. Ind. Pharm., 43, p. 1892, DOI: 10.1080/03639045.2017.1353521</label>
          <listPosition>97</listPosition>
          <doi>10.1080/03639045.2017.1353521</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478601</mtid>
          <link>/api/reference/47478601</link>
          <label>98. Tang 2015: Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation., Drug Deliv., 22, p. 608, DOI: 10.3109/10717544.2013.863526</label>
          <listPosition>98</listPosition>
          <doi>10.3109/10717544.2013.863526</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478602</mtid>
          <link>/api/reference/47478602</link>
          <label>99. Adel 2021: Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin., Int. J. Nanomed., 16, p. 2667, DOI: 10.2147/IJN.S306831</label>
          <listPosition>99</listPosition>
          <doi>10.2147/IJN.S306831</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478603</mtid>
          <link>/api/reference/47478603</link>
          <label>100. Gandhi 2015: Inhalable liposomal dry powder of gemcitabine-HCl: Formulation, in vitro characterization and in vivo studies., Int. J. Pharm., 496, p. 886, DOI: 10.1016/j.ijpharm.2015.10.020</label>
          <listPosition>100</listPosition>
          <doi>10.1016/j.ijpharm.2015.10.020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478604</mtid>
          <link>/api/reference/47478604</link>
          <label>101. Huang 2010: Development of liposomal salbutamol sulfate dry powder inhaler formulation., Biol. Pharm. Bull, 33, p. 512, DOI: 10.1248/bpb.33.512</label>
          <listPosition>101</listPosition>
          <doi>10.1248/bpb.33.512</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478605</mtid>
          <link>/api/reference/47478605</link>
          <label>102. Chen 2012: Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery., Int. J. Nanomed., 7, p. 1139</label>
          <listPosition>102</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478606</mtid>
          <link>/api/reference/47478606</link>
          <label>103. Changsan 2009: Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation., J. Pharm. Sci., 98, p. 628, DOI: 10.1002/jps.21441</label>
          <listPosition>103</listPosition>
          <doi>10.1002/jps.21441</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478607</mtid>
          <link>/api/reference/47478607</link>
          <label>104. Chougule 2007: Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics., Int. J. Nanomed., 2, p. 675</label>
          <listPosition>104</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478608</mtid>
          <link>/api/reference/47478608</link>
          <label>105. Chougule 2008: Development of Spray Dried Liposomal Dry Powder Inhaler of Dapsone., AAPS PharmSciTech, 9, p. 47, DOI: 10.1208/s12249-007-9024-6</label>
          <listPosition>105</listPosition>
          <doi>10.1208/s12249-007-9024-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478609</mtid>
          <link>/api/reference/47478609</link>
          <label>106. Zhang 2018: Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers., Acta Pharm. Sin. B, 8, p. 440, DOI: 10.1016/j.apsb.2018.03.004</label>
          <listPosition>106</listPosition>
          <doi>10.1016/j.apsb.2018.03.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478610</mtid>
          <link>/api/reference/47478610</link>
          <label>107. Hamishehkar 2015: Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: Solid-state characterization and aerosol dispersion performance., Drug Dev. Ind. Pharm., 41, p. 1431, DOI: 10.3109/03639045.2014.956111</label>
          <listPosition>107</listPosition>
          <doi>10.3109/03639045.2014.956111</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478611</mtid>
          <link>/api/reference/47478611</link>
          <label>108. Varshosaz, J., Ghaffari, S., Mirshojaei, S.F., Jafarian, A., Atyabi, F., Kobarfard, F., and Azarmi, S. (2013). Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery. Biomed Res. Int., 2013., DOI: 10.1155/2013/136859</label>
          <listPosition>108</listPosition>
          <doi>10.1155/2013/136859</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478612</mtid>
          <link>/api/reference/47478612</link>
          <label>109. Mussi 2013: New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles., Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci., 48, p. 282</label>
          <listPosition>109</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478613</mtid>
          <link>/api/reference/47478613</link>
          <label>110. Bi 2009: Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery., J. Biomed. Nanotechnol., 5, p. 84, DOI: 10.1166/jbn.2009.036</label>
          <listPosition>110</listPosition>
          <doi>10.1166/jbn.2009.036</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478614</mtid>
          <link>/api/reference/47478614</link>
          <label>111. Maretti 2016: Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability., Int. J. Pharm., 511, p. 669, DOI: 10.1016/j.ijpharm.2016.07.062</label>
          <listPosition>111</listPosition>
          <doi>10.1016/j.ijpharm.2016.07.062</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478615</mtid>
          <link>/api/reference/47478615</link>
          <label>112. Emami 2015: Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design., Res. Pharm. Sci., 10, p. 17</label>
          <listPosition>112</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478616</mtid>
          <link>/api/reference/47478616</link>
          <label>113. Bohr 2017: Formulation and process considerations for the design of sildenafil-loaded polymeric microparticles by vibrational spray-drying., Pharm. Dev. Technol., 22, p. 691, DOI: 10.3109/10837450.2015.1098661</label>
          <listPosition>113</listPosition>
          <doi>10.3109/10837450.2015.1098661</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478617</mtid>
          <link>/api/reference/47478617</link>
          <label>114. Puri 2022: Inhalation potential of N-Acetylcysteine loaded PLGA nanoparticles for the management of tuberculosis: In vitro lung deposition and efficacy studies., Curr. Res. Pharmacol. Drug Discov., 3, p. 100084, DOI: 10.1016/j.crphar.2022.100084</label>
          <listPosition>114</listPosition>
          <doi>10.1016/j.crphar.2022.100084</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478618</mtid>
          <link>/api/reference/47478618</link>
          <label>115. Brea 2009: Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma., Int. J. Pharm., 381, p. 122, DOI: 10.1016/j.ijpharm.2009.04.009</label>
          <listPosition>115</listPosition>
          <doi>10.1016/j.ijpharm.2009.04.009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478619</mtid>
          <link>/api/reference/47478619</link>
          <label>116. Mohtar 2017: Design and development of dry powder sulfobutylether-β-cyclodextrin complex for pulmonary delivery of fisetin., Eur. J. Pharm. Biopharm., 113, p. 1, DOI: 10.1016/j.ejpb.2016.11.036</label>
          <listPosition>116</listPosition>
          <doi>10.1016/j.ejpb.2016.11.036</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478620</mtid>
          <link>/api/reference/47478620</link>
          <label>117. Merchant 2017: Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity., J. Aerosol Med. Pulm. Drug Deliv., 30, p. 274, DOI: 10.1089/jamp.2016.1316</label>
          <listPosition>117</listPosition>
          <doi>10.1089/jamp.2016.1316</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478621</mtid>
          <link>/api/reference/47478621</link>
          <label>118. Taki 2016: Fabrication of nanocomposite particles using a two-solution mixing-type spray nozzle for use in an inhaled curcumin formulation., Int. J. Pharm., 511, p. 104, DOI: 10.1016/j.ijpharm.2016.06.134</label>
          <listPosition>118</listPosition>
          <doi>10.1016/j.ijpharm.2016.06.134</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478622</mtid>
          <link>/api/reference/47478622</link>
          <label>119. Mali 2017: In Vitro and In Vivo Performance of Novel Spray Dried Andrographolide Loaded Scleroglucan Based Formulation for Dry Powder Inhaler., Curr. Drug Deliv., 14, p. 968, DOI: 10.2174/1567201814666161109120455</label>
          <listPosition>119</listPosition>
          <doi>10.2174/1567201814666161109120455</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478623</mtid>
          <link>/api/reference/47478623</link>
          <label>120. Jiang 2021: A dry powder inhalable formulation of salvianolic acids for the treatment of pulmonary fibrosis: Safety, lung deposition, and pharmacokinetic study., Drug Deliv. Transl. Res., 11, p. 1958, DOI: 10.1007/s13346-020-00857-7</label>
          <listPosition>120</listPosition>
          <doi>10.1007/s13346-020-00857-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478624</mtid>
          <link>/api/reference/47478624</link>
          <label>121. Sung 2009: Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery., Pharm. Res., 26, p. 1847, DOI: 10.1007/s11095-009-9894-2</label>
          <listPosition>121</listPosition>
          <doi>10.1007/s11095-009-9894-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478625</mtid>
          <link>/api/reference/47478625</link>
          <label>122. Cheow 2011: Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: Effect of freeze-drying adjuvants., Int. J. Pharm., 404, p. 289, DOI: 10.1016/j.ijpharm.2010.11.021</label>
          <listPosition>122</listPosition>
          <doi>10.1016/j.ijpharm.2010.11.021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478626</mtid>
          <link>/api/reference/47478626</link>
          <label>123. Kyadarkunte 2014: Montelukast-loaded nanostructured lipid carriers: Part II Pulmonary drug delivery and in vitro–in vivo aerosol performance., Eur. J. Pharm. Biopharm., 88, p. 169, DOI: 10.1016/j.ejpb.2014.07.007</label>
          <listPosition>123</listPosition>
          <doi>10.1016/j.ejpb.2014.07.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478627</mtid>
          <link>/api/reference/47478627</link>
          <label>124. Kaur 2016: Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design., Drug Deliv., 23, p. 1912</label>
          <listPosition>124</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478628</mtid>
          <link>/api/reference/47478628</link>
          <label>125. Plumley 2009: Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy., Int. J. Pharm., 369, p. 136, DOI: 10.1016/j.ijpharm.2008.10.016</label>
          <listPosition>125</listPosition>
          <doi>10.1016/j.ijpharm.2008.10.016</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478629</mtid>
          <link>/api/reference/47478629</link>
          <label>126. Hu 2015: Evaluation of High-Performance Curcumin Nanocrystals for Pulmonary Drug Delivery Both In Vitro and In Vivo., Nanoscale Res. Lett., 10, p. 381, DOI: 10.1186/s11671-015-1085-y</label>
          <listPosition>126</listPosition>
          <doi>10.1186/s11671-015-1085-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478630</mtid>
          <link>/api/reference/47478630</link>
          <label>127. Kurniawansyah 2015: Inhalable curcumin formulations by supercritical technology., Powder Technol., 284, p. 289, DOI: 10.1016/j.powtec.2015.04.083</label>
          <listPosition>127</listPosition>
          <doi>10.1016/j.powtec.2015.04.083</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478631</mtid>
          <link>/api/reference/47478631</link>
          <label>128. Zhang 2011: Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal., Int. J. Pharm., 420, p. 180, DOI: 10.1016/j.ijpharm.2011.08.023</label>
          <listPosition>128</listPosition>
          <doi>10.1016/j.ijpharm.2011.08.023</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478632</mtid>
          <link>/api/reference/47478632</link>
          <label>129. Neumiller 2010: Technosphere® Insulin., BioDrugs, 24, p. 165, DOI: 10.2165/11536700-000000000-00000</label>
          <listPosition>129</listPosition>
          <doi>10.2165/11536700-000000000-00000</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478633</mtid>
          <link>/api/reference/47478633</link>
          <label>130. Geller 2011: Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology., J. Aerosol Med. Pulm. Drug Deliv., 24, p. 175, DOI: 10.1089/jamp.2010.0855</label>
          <listPosition>130</listPosition>
          <doi>10.1089/jamp.2010.0855</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478634</mtid>
          <link>/api/reference/47478634</link>
          <label>131. Singh 2018: The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease., Br. J. Clin. Pharmacol., 84, p. 2097, DOI: 10.1111/bcp.13645</label>
          <listPosition>131</listPosition>
          <doi>10.1111/bcp.13645</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478635</mtid>
          <link>/api/reference/47478635</link>
          <label>132. Rajabnezhad 2016: Pulmonary delivery of rifampicin microspheres using lower generation polyamidoamine dendrimers as a carrier., Powder Technol., 291, p. 366, DOI: 10.1016/j.powtec.2015.12.037</label>
          <listPosition>132</listPosition>
          <doi>10.1016/j.powtec.2015.12.037</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478636</mtid>
          <link>/api/reference/47478636</link>
          <label>133. Shen, Q., Jiang, Y., Chen, J., Wang, X., and Zheng, J. (2021). A Novel Curcumin-Based Drug Powder Inhalation Medicine for Chronic Obstructive Pulmonary Disease. Bioinorg. Chem. Appl., 2021., DOI: 10.1155/2021/8001787</label>
          <listPosition>133</listPosition>
          <doi>10.1155/2021/8001787</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478637</mtid>
          <link>/api/reference/47478637</link>
          <label>134. Agnoletti 2017: Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying., Eur. J. Pharm. Biopharm., 120, p. 9, DOI: 10.1016/j.ejpb.2017.08.001</label>
          <listPosition>134</listPosition>
          <doi>10.1016/j.ejpb.2017.08.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478638</mtid>
          <link>/api/reference/47478638</link>
          <label>135. Zhong 2018: Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance., AAPS PharmSciTech, 19, p. 531, DOI: 10.1208/s12249-017-0859-1</label>
          <listPosition>135</listPosition>
          <doi>10.1208/s12249-017-0859-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478639</mtid>
          <link>/api/reference/47478639</link>
          <label>136. Shahin 2023: A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications., J. Drug Deliv. Sci. Technol., 84, p. 104553, DOI: 10.1016/j.jddst.2023.104553</label>
          <listPosition>136</listPosition>
          <doi>10.1016/j.jddst.2023.104553</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478640</mtid>
          <link>/api/reference/47478640</link>
          <label>137. Dunber 1998: Dispersion and characterization of pharmaceutical dry powder aerosols., KONA Powder Part. J., 16, p. 7, DOI: 10.14356/kona.1998007</label>
          <listPosition>137</listPosition>
          <doi>10.14356/kona.1998007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478641</mtid>
          <link>/api/reference/47478641</link>
          <label>138. Frijlink 2004: Dry powder inhalers for pulmonary drug delivery., Expert Opin. Drug Deliv., 1, p. 67, DOI: 10.1517/17425247.1.1.67</label>
          <listPosition>138</listPosition>
          <doi>10.1517/17425247.1.1.67</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478642</mtid>
          <link>/api/reference/47478642</link>
          <label>139. Ibrahim 2015: Inhalation drug delivery devices: Technology update., Med. Devices, 8, p. 131</label>
          <listPosition>139</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478643</mtid>
          <link>/api/reference/47478643</link>
          <label>140. Chan 2014: A Novel Inhalable Form of Rifapentine., J. Pharm. Sci., 103, p. 1411, DOI: 10.1002/jps.23911</label>
          <listPosition>140</listPosition>
          <doi>10.1002/jps.23911</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478644</mtid>
          <link>/api/reference/47478644</link>
          <label>141. Claus 2014: How can we bring high drug doses to the lung?., Eur. J. Pharm. Biopharm., 86, p. 1, DOI: 10.1016/j.ejpb.2013.11.005</label>
          <listPosition>141</listPosition>
          <doi>10.1016/j.ejpb.2013.11.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478645</mtid>
          <link>/api/reference/47478645</link>
          <label>142. Varun 2022: Engineered inhalable micro-balloon shaped drug particles for carrier-free dry powder inhalation (DPI) application., Powder Technol., 408, p. 117705, DOI: 10.1016/j.powtec.2022.117705</label>
          <listPosition>142</listPosition>
          <doi>10.1016/j.powtec.2022.117705</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478646</mtid>
          <link>/api/reference/47478646</link>
          <label>143. Lechanteur, A., and Evrard, B. (2020). Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review. Pharmaceutics, 12., DOI: 10.3390/pharmaceutics12010055</label>
          <listPosition>143</listPosition>
          <doi>10.3390/pharmaceutics12010055</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478647</mtid>
          <link>/api/reference/47478647</link>
          <label>144. Wong, S.N., Weng, J., Ip, I., Chen, R., Lakerveld, R., Telford, R., Blagden, N., Scowen, I.J., and Chow, S.F. (2022). Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline. Pharmaceutics, 14., DOI: 10.3390/pharmaceutics14020300</label>
          <listPosition>144</listPosition>
          <doi>10.3390/pharmaceutics14020300</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478648</mtid>
          <link>/api/reference/47478648</link>
          <label>145. Alhajj 2021: Designing enhanced spray dried particles for inhalation: A review of the impact of excipients and processing parameters on particle properties., Powder Technol., 384, p. 313, DOI: 10.1016/j.powtec.2021.02.031</label>
          <listPosition>145</listPosition>
          <doi>10.1016/j.powtec.2021.02.031</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478649</mtid>
          <link>/api/reference/47478649</link>
          <label>146. Azari 2020: Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery., Drug Res., 70, p. 26, DOI: 10.1055/a-0649-0814</label>
          <listPosition>146</listPosition>
          <doi>10.1055/a-0649-0814</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478650</mtid>
          <link>/api/reference/47478650</link>
          <label>147. Chan 2012: A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect?., Adv. Drug Deliv. Rev., 64, p. 257, DOI: 10.1016/j.addr.2011.04.004</label>
          <listPosition>147</listPosition>
          <doi>10.1016/j.addr.2011.04.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478651</mtid>
          <link>/api/reference/47478651</link>
          <label>148. Guchardi 2008: Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations., Int. J. Pharm., 348, p. 10, DOI: 10.1016/j.ijpharm.2007.06.041</label>
          <listPosition>148</listPosition>
          <doi>10.1016/j.ijpharm.2007.06.041</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478652</mtid>
          <link>/api/reference/47478652</link>
          <label>149. Lavorini 2017: Recent advances in capsule-based dry powder inhaler technology., Multidiscip. Respir. Med., 12, p. 11, DOI: 10.1186/s40248-017-0092-5</label>
          <listPosition>149</listPosition>
          <doi>10.1186/s40248-017-0092-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478653</mtid>
          <link>/api/reference/47478653</link>
          <label>150. Edwards 2010: Applications of capsule dosing techniques for use in dry powder inhalers., Ther. Deliv., 1, p. 195, DOI: 10.4155/tde.10.1</label>
          <listPosition>150</listPosition>
          <doi>10.4155/tde.10.1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478654</mtid>
          <link>/api/reference/47478654</link>
          <label>151. Magramane 2019: Formulation and Characterization of Pulmonary Drug Delivery Systems., Acta Pharm. Hung., 89, p. 63</label>
          <listPosition>151</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478655</mtid>
          <link>/api/reference/47478655</link>
          <label>152. Sibum 2018: Challenges for pulmonary delivery of high powder doses., Int. J. Pharm., 548, p. 325, DOI: 10.1016/j.ijpharm.2018.07.008</label>
          <listPosition>152</listPosition>
          <doi>10.1016/j.ijpharm.2018.07.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478656</mtid>
          <link>/api/reference/47478656</link>
          <label>153. Smith 2003: The inhalers of the future? A review of dry powder devices on the market today., Pulm. Pharmacol. Ther., 16, p. 79, DOI: 10.1016/S1094-5539(02)00147-5</label>
          <listPosition>153</listPosition>
          <doi>10.1016/S1094-5539(02)00147-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478657</mtid>
          <link>/api/reference/47478657</link>
          <label>154. Grasmeijer 2015: Recent advances in the fundamental understanding of adhesive mixtures for inhalation., Curr. Pharm. Des., 21, p. 5900, DOI: 10.2174/1381612821666151008124622</label>
          <listPosition>154</listPosition>
          <doi>10.2174/1381612821666151008124622</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478658</mtid>
          <link>/api/reference/47478658</link>
          <label>155. Gharse 2016: Large Porous Hollow Particles: Lightweight Champions of Pulmonary Drug Delivery., Curr. Pharm. Des., 22, p. 2463, DOI: 10.2174/1381612822666160128145356</label>
          <listPosition>155</listPosition>
          <doi>10.2174/1381612822666160128145356</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478659</mtid>
          <link>/api/reference/47478659</link>
          <label>156. Mohan, A.R., Wang, Q., Dhapare, S., Bielski, E., Kaviratna, A., Han, L., Boc, S., and Newman, B. (2022). Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development. Pharmaceutics, 14., DOI: 10.3390/pharmaceutics14112495</label>
          <listPosition>156</listPosition>
          <doi>10.3390/pharmaceutics14112495</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478660</mtid>
          <link>/api/reference/47478660</link>
          <label>157. Edwards 1997: Large porous particles for pulmonary drug delivery., Science, 276, p. 1868, DOI: 10.1126/science.276.5320.1868</label>
          <listPosition>157</listPosition>
          <doi>10.1126/science.276.5320.1868</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478661</mtid>
          <link>/api/reference/47478661</link>
          <label>158. Hagedoorn 2006: Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer®) for high powder doses., Eur. J. Pharm. Sci., 28, p. 171, DOI: 10.1016/j.ejps.2005.11.013</label>
          <listPosition>158</listPosition>
          <doi>10.1016/j.ejps.2005.11.013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478662</mtid>
          <link>/api/reference/47478662</link>
          <label>159. Uddin 2016: Pharmacopoeial Standards and Specifications for Pharmaceutical Aerosols: In-Process and Finished Products Quality Control Tests., Adv. Res., 6, p. 1, DOI: 10.9734/AIR/2016/22442</label>
          <listPosition>159</listPosition>
          <doi>10.9734/AIR/2016/22442</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478663</mtid>
          <link>/api/reference/47478663</link>
          <label>160. Kulkarni 2017: Effect of Formulation Excipients on Aerosolisation Performance of Budesonide., Indo Am. J. Pharm. Res., 7, p. 909</label>
          <listPosition>160</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478664</mtid>
          <link>/api/reference/47478664</link>
          <label>161. Agu 2011: In vitro and in vivo testing methods for respiratory drug delivery., Expert Opin. Drug Deliv., 8, p. 57, DOI: 10.1517/17425247.2011.543896</label>
          <listPosition>161</listPosition>
          <doi>10.1517/17425247.2011.543896</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478665</mtid>
          <link>/api/reference/47478665</link>
          <label>162. Ho, K.K.L., Kellaway, I.W., and Tredree, R. (2011). Particle Size Analysis of Nebulised Aerosols Using Fraunhofer Laser Diffraction and Inertial Compaction Methods. J. Pharm. Pharmacol., 38., DOI: 10.1111/j.2042-7158.1986.tb14255.x</label>
          <listPosition>162</listPosition>
          <doi>10.1111/j.2042-7158.1986.tb14255.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478666</mtid>
          <link>/api/reference/47478666</link>
          <label>163. Radivojev 2019: Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs., Int. J. Pharm., 556, p. 45, DOI: 10.1016/j.ijpharm.2018.11.072</label>
          <listPosition>163</listPosition>
          <doi>10.1016/j.ijpharm.2018.11.072</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478667</mtid>
          <link>/api/reference/47478667</link>
          <label>164. Eedara 2019: In vitro dissolution testing of respirable size anti-tubercular drug particles using a small volume dissolution apparatus., Int. J. Pharm., 559, p. 235, DOI: 10.1016/j.ijpharm.2019.01.035</label>
          <listPosition>164</listPosition>
          <doi>10.1016/j.ijpharm.2019.01.035</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478668</mtid>
          <link>/api/reference/47478668</link>
          <label>165. May 2012: Dissolution techniques for in vitro testing of dry powders for inhalation., Pharm. Res., 29, p. 2157, DOI: 10.1007/s11095-012-0744-2</label>
          <listPosition>165</listPosition>
          <doi>10.1007/s11095-012-0744-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478669</mtid>
          <link>/api/reference/47478669</link>
          <label>166. Nokhodchi, A., Chavan, S., and Ghafourian, T. (2023). In Vitro Dissolution and Permeability Testing of Inhalation Products: Challenges and Advances. Pharmaceutics, 15., DOI: 10.3390/pharmaceutics15030983</label>
          <listPosition>166</listPosition>
          <doi>10.3390/pharmaceutics15030983</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478670</mtid>
          <link>/api/reference/47478670</link>
          <label>167. Son 2009: Development of a standardized dissolution test method for inhaled pharmaceutical formulations., Int. J. Pharm., 382, p. 15, DOI: 10.1016/j.ijpharm.2009.07.034</label>
          <listPosition>167</listPosition>
          <doi>10.1016/j.ijpharm.2009.07.034</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478671</mtid>
          <link>/api/reference/47478671</link>
          <label>168. Davies 2003: A novel method for assessing dissolution of aerosol inhaler products., Int. J. Pharm., 255, p. 175, DOI: 10.1016/S0378-5173(03)00091-7</label>
          <listPosition>168</listPosition>
          <doi>10.1016/S0378-5173(03)00091-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478672</mtid>
          <link>/api/reference/47478672</link>
          <label>169. Salama 2008: Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: Evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols., Eur. J. Pharm. Biopharm., 70, p. 145, DOI: 10.1016/j.ejpb.2008.04.009</label>
          <listPosition>169</listPosition>
          <doi>10.1016/j.ejpb.2008.04.009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478673</mtid>
          <link>/api/reference/47478673</link>
          <label>170. Marques 2011: Simulated Biological Fluids with Possible Application in Dissolution Testing., Dissolution Technol., 18, p. 15, DOI: 10.14227/DT180311P15</label>
          <listPosition>170</listPosition>
          <doi>10.14227/DT180311P15</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478674</mtid>
          <link>/api/reference/47478674</link>
          <label>171. Moss, O.R. (1979). Simulants of Lung Interstitial Fluid, National Library of Medicine.</label>
          <listPosition>171</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478675</mtid>
          <link>/api/reference/47478675</link>
          <label>172. Hassoun 2018: Design and development of a biorelevant simulated human lung fluid., J. Drug Deliv. Sci. Technol., 47, p. 485, DOI: 10.1016/j.jddst.2018.08.006</label>
          <listPosition>172</listPosition>
          <doi>10.1016/j.jddst.2018.08.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478676</mtid>
          <link>/api/reference/47478676</link>
          <label>173. 2000: Scanning electron microscopy: An introduction., III-Vs Rev., 13, p. 40</label>
          <listPosition>173</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478677</mtid>
          <link>/api/reference/47478677</link>
          <label>174. Scimeca 2018: Energy Dispersive X-ray (EDX) microanalysis: A powerful tool in biomedical research and diagnosis., Eur. J. Histochem., 62, p. 2841</label>
          <listPosition>174</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478678</mtid>
          <link>/api/reference/47478678</link>
          <label>175. Mahler 2017: Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease., Ann. Am. Thorac. Soc., 14, p. 1103</label>
          <listPosition>175</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478679</mtid>
          <link>/api/reference/47478679</link>
          <label>176. 2015: Dry powder inhalers and the right things to remember: A concept review., Multidiscip. Respir. Med., 10, p. 13, DOI: 10.1186/s40248-015-0012-5</label>
          <listPosition>176</listPosition>
          <doi>10.1186/s40248-015-0012-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478680</mtid>
          <link>/api/reference/47478680</link>
          <label>177. Locatelli 2020: Inhalation technique and asthma outcomes with different corticosteroid-containing inhaler devices., J. Asthma, 57, p. 654, DOI: 10.1080/02770903.2019.1591442</label>
          <listPosition>177</listPosition>
          <doi>10.1080/02770903.2019.1591442</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478681</mtid>
          <link>/api/reference/47478681</link>
          <label>178. Arora 2014: Evaluating the technique of using inhalation device in COPD and Bronchial Asthma patients., Respir. Med., 108, p. 992, DOI: 10.1016/j.rmed.2014.04.021</label>
          <listPosition>178</listPosition>
          <doi>10.1016/j.rmed.2014.04.021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478682</mtid>
          <link>/api/reference/47478682</link>
          <label>179. Molimard 2003: Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care., J. Aerosol Med., 16, p. 249, DOI: 10.1089/089426803769017613</label>
          <listPosition>179</listPosition>
          <doi>10.1089/089426803769017613</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478683</mtid>
          <link>/api/reference/47478683</link>
          <label>180. Richter 2004: Successful use of DPI systems in asthmatic patients–key parameters., Respir. Med., 98, p. S22, DOI: 10.1016/j.rmed.2004.07.013</label>
          <listPosition>180</listPosition>
          <doi>10.1016/j.rmed.2004.07.013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478684</mtid>
          <link>/api/reference/47478684</link>
          <label>181. Benke, E., Varga, P., Szabó-Révész, P., and Ambrus, R. (2021). Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types. Pharmaceutics, 13., DOI: 10.3390/pharmaceutics13050689</label>
          <listPosition>181</listPosition>
          <doi>10.3390/pharmaceutics13050689</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478685</mtid>
          <link>/api/reference/47478685</link>
          <label>182. Ding 2022: Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations., AAPS PharmSciTech, 23, p. 52, DOI: 10.1208/s12249-021-02175-8</label>
          <listPosition>182</listPosition>
          <doi>10.1208/s12249-021-02175-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478686</mtid>
          <link>/api/reference/47478686</link>
          <label>183. Milind, K., Biyani, A.K., Fernando, D., Ettore, C., and Erwin, P. (2023, August 03). Emerging Trends in Blister-Based Dry Powder Inhalers. Available online: https://pharma-trends.com/2021/01/14/emerging-trends-in-blister-based-dry-powder-inhalers/.</label>
          <listPosition>183</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478687</mtid>
          <link>/api/reference/47478687</link>
          <label>184. Pfizer (2023, August 03). Exubera 1 mg Inhalation Powder Pre-Dispensed SmPC. Available online: https://www.ema.europa.eu/en/documents/product-information/exubera-epar-product-information_en.pdf.</label>
          <listPosition>184</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478688</mtid>
          <link>/api/reference/47478688</link>
          <label>185. Chang 2021: Dry powder pharmaceutical biologics for inhalation therapy., Adv. Drug Deliv. Rev., 172, p. 64, DOI: 10.1016/j.addr.2021.02.017</label>
          <listPosition>185</listPosition>
          <doi>10.1016/j.addr.2021.02.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478689</mtid>
          <link>/api/reference/47478689</link>
          <label>186. Zhou 2014: Emerging inhalation aerosol devices and strategies: Where are we headed?., Adv. Drug Deliv. Rev., 75, p. 3, DOI: 10.1016/j.addr.2014.03.006</label>
          <listPosition>186</listPosition>
          <doi>10.1016/j.addr.2014.03.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478690</mtid>
          <link>/api/reference/47478690</link>
          <label>187. Labiris 2003: Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications., Br. J. Clin. Pharmacol., 56, p. 600, DOI: 10.1046/j.1365-2125.2003.01893.x</label>
          <listPosition>187</listPosition>
          <doi>10.1046/j.1365-2125.2003.01893.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478691</mtid>
          <link>/api/reference/47478691</link>
          <label>188. Telg 2016: Need of education for dry powder inhaler storage and retention–-a patient-reported survey., Multidiscip. Respir. Med., 11, p. 21, DOI: 10.1186/s40248-016-0057-0</label>
          <listPosition>188</listPosition>
          <doi>10.1186/s40248-016-0057-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478692</mtid>
          <link>/api/reference/47478692</link>
          <label>189. (2023, September 07). 3M™ Drug Delivery Systems. Available online: https://news.3m.com/2016-04-19-3M-Unveils-Intelligent-Inhaler-Designed-to-Help-Control-Spiraling-Costs-of-Respiratory-Disease.</label>
          <listPosition>189</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478693</mtid>
          <link>/api/reference/47478693</link>
          <label>190. Crompton 2004: How to achieve good compliance with inhaled asthma therapy., Respir. Med., 98, p. S35, DOI: 10.1016/j.rmed.2004.07.014</label>
          <listPosition>190</listPosition>
          <doi>10.1016/j.rmed.2004.07.014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478694</mtid>
          <link>/api/reference/47478694</link>
          <label>191. Kolewe 2023: A Pediatric Upper Airway Library to Evaluate Interpatient Variability of In Silico Aerosol Deposition., AAPS PharmSciTech, 24, p. 162, DOI: 10.1208/s12249-023-02619-3</label>
          <listPosition>191</listPosition>
          <doi>10.1208/s12249-023-02619-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478695</mtid>
          <link>/api/reference/47478695</link>
          <label>192. Ungaro 2014: Improving the efficacy of inhaled drugs for severe lung diseases: Emerging pulmonary delivery strategies., Adv. Drug Deliv. Rev., 75, p. 1, DOI: 10.1016/j.addr.2014.08.001</label>
          <listPosition>192</listPosition>
          <doi>10.1016/j.addr.2014.08.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478696</mtid>
          <link>/api/reference/47478696</link>
          <label>193. Gaikwad 2023: Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies., J. Control. Release, 355, p. 292, DOI: 10.1016/j.jconrel.2023.01.083</label>
          <listPosition>193</listPosition>
          <doi>10.1016/j.jconrel.2023.01.083</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478697</mtid>
          <link>/api/reference/47478697</link>
          <label>194. Mehta 2021: Dry powder inhalers: A concise summary of the electronic monitoring devices., Ther. Deliv., 12, p. 1, DOI: 10.4155/tde-2020-0091</label>
          <listPosition>194</listPosition>
          <doi>10.4155/tde-2020-0091</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478698</mtid>
          <link>/api/reference/47478698</link>
          <label>195. Kumar 2022: Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications., Pharm. Res., 39, p. 2831, DOI: 10.1007/s11095-022-03286-y</label>
          <listPosition>195</listPosition>
          <doi>10.1007/s11095-022-03286-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478699</mtid>
          <link>/api/reference/47478699</link>
          <label>196. (2023, May 21). Electronic Medicines Compendium (EMC). Available online: https://www.medicines.org.uk/emc/.</label>
          <listPosition>196</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478700</mtid>
          <link>/api/reference/47478700</link>
          <label>197. (2023, May 21). European Medicines Agency (EMA). Available online: https://www.ema.europa.eu/en.</label>
          <listPosition>197</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478701</mtid>
          <link>/api/reference/47478701</link>
          <label>198. (2023, May 22). RightBreathe. Available online: https://www.rightbreathe.com/.</label>
          <listPosition>198</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478702</mtid>
          <link>/api/reference/47478702</link>
          <label>199. DePietro 2018: Inhalation device options for the management of chronic obstructive pulmonary disease., Postgrad. Med., 130, p. 83, DOI: 10.1080/00325481.2018.1399042</label>
          <listPosition>199</listPosition>
          <doi>10.1080/00325481.2018.1399042</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478703</mtid>
          <link>/api/reference/47478703</link>
          <label>200. (2023, November 13). Digihaler. Available online: https://www.digihaler.com/inhalers.</label>
          <listPosition>200</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478704</mtid>
          <link>/api/reference/47478704</link>
          <label>201. (2023, November 13). Propeller Health. Available online: https://propellerhealth.com/.</label>
          <listPosition>201</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478705</mtid>
          <link>/api/reference/47478705</link>
          <label>202. (2023, November 13). Adherium’s Hailie®. Available online: https://www.adherium.com/our-technology/.</label>
          <listPosition>202</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478706</mtid>
          <link>/api/reference/47478706</link>
          <label>203. Barrett 2016: Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence., Eur. Respir. J., 48, p. PA1018</label>
          <listPosition>203</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478707</mtid>
          <link>/api/reference/47478707</link>
          <label>204. Arendsen 2022: Smart dry powder inhalers and intelligent adherence management., Adv. Drug Deliv. Rev., 191, p. 114580, DOI: 10.1016/j.addr.2022.114580</label>
          <listPosition>204</listPosition>
          <doi>10.1016/j.addr.2022.114580</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478708</mtid>
          <link>/api/reference/47478708</link>
          <label>205. (2017). Biocompatibility Evaluation of Breathing Gas Pathways in Healthcare Applications—Part 1: Evaluation and Testing within a Risk Management Process (Standard No. ISO 18562-1:2017).</label>
          <listPosition>205</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478709</mtid>
          <link>/api/reference/47478709</link>
          <label>206. Giannopoulou 2016: In Vitro Cytotoxicity of Dry Powder Inhaler Medical Devices., Int. J. Res. Stud. Sci. Eng. Technol., 3, p. 7</label>
          <listPosition>206</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478710</mtid>
          <link>/api/reference/47478710</link>
          <label>207. Zillen 2021: Natural and bioinspired excipients for dry powder inhalation formulations., Curr. Opin. Colloid Interface Sci., 56, p. 101497, DOI: 10.1016/j.cocis.2021.101497</label>
          <listPosition>207</listPosition>
          <doi>10.1016/j.cocis.2021.101497</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478711</mtid>
          <link>/api/reference/47478711</link>
          <label>208. Stoilova 2023: Performance and biocompatibility of a novel inhalable dry powder formulation based on hyaluronic acid intended to protect the respiratory tract mucosa., Int. J. Pharm., 638, p. 122889, DOI: 10.1016/j.ijpharm.2023.122889</label>
          <listPosition>208</listPosition>
          <doi>10.1016/j.ijpharm.2023.122889</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478712</mtid>
          <link>/api/reference/47478712</link>
          <label>209. Lavorini 2014: New inhaler devices-the good, the bad and the ugly., Respiration, 88, p. 3, DOI: 10.1159/000363390</label>
          <listPosition>209</listPosition>
          <doi>10.1159/000363390</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478713</mtid>
          <link>/api/reference/47478713</link>
          <label>210. Levy 2016: Inhaler technique: Facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)., NPJ Prim. Care Respir. Med., 26, p. 16017, DOI: 10.1038/npjpcrm.2016.17</label>
          <listPosition>210</listPosition>
          <doi>10.1038/npjpcrm.2016.17</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478714</mtid>
          <link>/api/reference/47478714</link>
          <label>211. Chan 2014: Advances in Device and Formulation Technologies for Pulmonary Drug Delivery., AAPS PharmSciTech, 15, p. 882, DOI: 10.1208/s12249-014-0114-y</label>
          <listPosition>211</listPosition>
          <doi>10.1208/s12249-014-0114-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>47478715</mtid>
          <link>/api/reference/47478715</link>
          <label>212. Berkenfeld 2015: Devices for Dry Powder Drug Delivery to the Lung., AAPS PharmSciTech, 16, p. 479, DOI: 10.1208/s12249-015-0317-x</label>
          <listPosition>212</listPosition>
          <doi>10.1208/s12249-015-0317-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
      </references>
      <link>/api/publication/34405975</link>
      <label>Magramane Sabrina et al. Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. (2023) PHARMACEUTICALS 1424-8247 16 12</label><template>&lt;div class=&quot;JournalArticle Publication short-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;span class=&quot;author-name&quot; mtid=&quot;10071684&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10071684&quot; target=&quot;_blank&quot;&gt;Magramane, Sabrina&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10087474&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10087474&quot; target=&quot;_blank&quot;&gt;Vlahović, Kristina&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10013580&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10013580&quot; target=&quot;_blank&quot;&gt;Gordon, Péter&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10020629&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10020629&quot; target=&quot;_blank&quot;&gt;Kállai-Szabó, Nikolett ✉&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10002587&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10002587&quot; target=&quot;_blank&quot;&gt;Zelkó, Romána&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10020626&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10020626&quot; target=&quot;_blank&quot;&gt;Antal, István&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10061229&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10061229&quot; target=&quot;_blank&quot;&gt;Farkas, Dóra ✉&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; &lt;/div &gt;&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34405975&quot; mtid=&quot;34405975&quot; target=&quot;_blank&quot;&gt;Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements&lt;/a&gt;&lt;/div&gt; &lt;div class=&quot;pub-info&quot;&gt; &lt;span class=&quot;journal-title&quot;&gt;PHARMACEUTICALS&lt;/span&gt; &lt;span class=&quot;journal-volume&quot;&gt;16&lt;/span&gt; : &lt;span class=&quot;journal-issue&quot;&gt;12&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper: 1658 , 48 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-end&quot;&gt;&lt;div class=&quot;identifier-list&quot;&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.3390/ph16121658&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.3390/ph16121658&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;001131093800001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001131093800001&quot;&gt; WoS &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;85180680047&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85180680047&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;38139785&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=38139785&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;short-pub-prop-list&quot;&gt; &lt;span class=&quot;short-pub-mtid&quot;&gt; Közlemény:34405975 &lt;/span&gt; &lt;span class=&quot;status-holder&quot;&gt;&lt;span class=&quot;status-data status-VALIDATED&quot;&gt; Egyeztetett &lt;/span&gt;&lt;/span&gt; &lt;span class=&quot;pub-core&quot;&gt;Forrás Idéző &lt;/span&gt; &lt;span class=&quot;pub-type&quot;&gt;Folyóiratcikk (Összefoglaló cikk ) &lt;/span&gt; &lt;!-- &amp;&amp; !record.category.scientific --&gt; &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 53&lt;/span&gt; | Független: 52 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 37 | Scopus jelölt:&amp;nbsp;43 | WoS/Scopus jelölt:&amp;nbsp;44 | DOI jelölt:&amp;nbsp;48 &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;</template><template2>&lt;div class=&quot;JournalArticle Publication long-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;img title=&quot;Forrásközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-core-icon.png&quot;&gt; &lt;img title=&quot;Idézőközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-citation-icon.png&quot;&gt; &lt;div class=&quot;autype autype0&quot;&gt; &lt;span class=&quot;author-name&quot; mtid=&quot;10071684&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10071684&quot; target=&quot;_blank&quot;&gt;Magramane Sabrina (&lt;span class=&quot;authorship-author-name&quot;&gt;MAGRAMANE Sabrina&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Pharmacy&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Gyógyszerésztudományi Kar&quot;&gt;GYTK&lt;/span&gt;/Gyógyszerészeti Intézet&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10087474&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10087474&quot; target=&quot;_blank&quot;&gt;Vlahović Kristina (&lt;span class=&quot;authorship-author-name&quot;&gt;Vlahovic Kristina&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; gyógyszertechnológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Gyógyszerésztudományi Kar&quot;&gt;GYTK&lt;/span&gt;/Gyógyszerészeti Intézet&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10013580&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10013580&quot; target=&quot;_blank&quot;&gt;Gordon Péter (&lt;span class=&quot;authorship-author-name&quot;&gt;Gordon Péter&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Hibaanalitika&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Budapesti Műszaki és Gazdaságtudományi Egyetem&quot;&gt;BME&lt;/span&gt;/&lt;span title=&quot;Villamosmérnöki és Informatikai Kar&quot;&gt;VIK&lt;/span&gt;/Elektronikai Technológia Tanszék&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10020629&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10020629&quot; target=&quot;_blank&quot;&gt;Kállai-Szabó Nikolett ✉ (&lt;span class=&quot;authorship-author-name&quot;&gt;Kállai-Szabó Nikolett&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Gyógyszertechnológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Gyógyszerésztudományi Kar&quot;&gt;GYTK&lt;/span&gt;/Gyógyszerészeti Intézet&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10002587&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10002587&quot; target=&quot;_blank&quot;&gt;Zelkó Romána (&lt;span class=&quot;authorship-author-name&quot;&gt;Zelkó Romána&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Gyógyszertechnológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Gyógyszerésztudományi Kar&quot;&gt;GYTK&lt;/span&gt;/Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10020626&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10020626&quot; target=&quot;_blank&quot;&gt;Antal István (&lt;span class=&quot;authorship-author-name&quot;&gt;Antal István&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Gyógyszertechnológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Gyógyszerésztudományi Kar&quot;&gt;GYTK&lt;/span&gt;/Gyógyszerészeti Intézet&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10061229&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10061229&quot; target=&quot;_blank&quot;&gt;Farkas Dóra ✉ (&lt;span class=&quot;authorship-author-name&quot;&gt;Farkas Dóra&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; gyógyszertechnológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Gyógyszerésztudományi Kar&quot;&gt;GYTK&lt;/span&gt;/Gyógyszerészeti Intézet&lt;/span&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34405975&quot; target=&quot;_blank&quot;&gt;Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements&lt;/a&gt;&lt;/div&gt; &lt;div&gt; &lt;span class=&quot;journal-title&quot;&gt;PHARMACEUTICALS&lt;/span&gt; &lt;span class=&quot;journal-issn&quot;&gt;( &lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/1424-8247&quot;&gt;1424-8247&lt;/a&gt;)&lt;/span&gt;: &lt;span class=&quot;journal-volume&quot;&gt;16&lt;/span&gt; &lt;span class=&quot;journal-issue&quot;&gt;12&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper 1658. 48 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-footer&quot;&gt;  &lt;span class=&quot;language&quot; xmlns=&quot;http://www.w3.org/1999/html&quot;&gt;Nyelv: Angol | &lt;/span&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.3390/ph16121658&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.3390/ph16121658&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;001131093800001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001131093800001&quot;&gt; WoS &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;85180680047&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85180680047&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;38139785&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=38139785&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;OnlyViewableByAuthor&gt;&lt;div class=&quot;ratings&quot;&gt; &lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Pharmaceutical Science&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q1&lt;/div&gt; &lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Drug Discovery&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q2&lt;/div&gt; &lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Molecular Medicine&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;Q2&lt;/div&gt; &lt;/div&gt;&lt;/OnlyViewableByAuthor&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 53&lt;/span&gt; | Független: 52 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 37 | Scopus jelölt:&amp;nbsp;43 | WoS/Scopus jelölt:&amp;nbsp;44 | DOI jelölt:&amp;nbsp;48 &lt;/div&gt;   &lt;div class=&quot;publication-citation&quot;&gt; &lt;a target=&quot;_blank&quot; href=&quot;/api/publication?cond=citations.related;eq;34405975&amp;sort=publishedYear,desc&amp;sort=title&quot;&gt; Idézett közlemények száma: 3 &lt;/a&gt; &lt;/div&gt; &lt;div class=&quot;mtid&quot;&gt;&lt;span class=&quot;long-pub-mtid&quot;&gt;Közlemény: 34405975&lt;/span&gt; | &lt;span class=&quot;status-data status-VALIDATED&quot;&gt; Egyeztetett &lt;/span&gt; Forrás Idéző | &lt;span class=&quot;type-subtype&quot;&gt;Folyóiratcikk ( Összefoglaló cikk ) &lt;/span&gt; | &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; | &lt;span class=&quot;publication-sourceOfData&quot;&gt;kézi felvitel&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;lastModified&quot;&gt;Utolsó módosítás: 2025.07.11. 09:56 Gere Tamásné (SE_KK_Admin5_GT, admin) &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;</template2>
    </publication>
  </content>
</myciteResult>
